Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:53:40 EDT Sat 04 May 2024
Enter Symbol
or Name
USA
CA



News for U:ADXS from 2023-05-04 to 2024-05-03 - 14 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-03-26 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces Completion of Sale of AL102 to Immunome
2024-02-20 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid Tumors
2024-02-06 08:00U:ADXSNews ReleaseImmunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
2024-02-06 08:00U:ADXSNews ReleaseImmunome To Acquire AL102, A Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
2023-11-06 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors
2023-10-23 07:00U:ADXSNews ReleaseAyala Pharmaceuticals Presents Updated AL102 Results from Phase 2 Clinical Trial in Desmoid Tumors at ESMO Congress 2023
2023-10-19 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces Closing of Merger with Biosight
2023-08-10 16:30U:ADXSNews ReleaseAyala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update
2023-08-01 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces Abstracts on AL102 and AL101 Accepted for Presentation at ESMO Congress 2023
2023-07-27 08:10U:ADXSNews ReleaseAyala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
2023-07-05 08:00U:ADXSNews ReleaseAyala Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA Regarding AL102 for the Treatment of Desmoid Tumors
2023-06-05 08:00U:ADXSNews ReleaseUpdated RINGSIDE Phase 2 Results Featured in Poster Discussion Session at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
2023-05-25 17:05U:ADXSNews ReleaseAyala Pharmaceuticals Announces Updated RINGSIDE Phase 2 Results at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
2023-05-23 13:20U:ADXSNews ReleaseAyala Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Corporate Update